BioSpace News Archive

According to Report, the intranasal drug delivery devices market size is predicted to hit USD 2.98 billion by 2030 and growing at a CAGR of 12.8% from 2021 to 2030.

According to Precedence Research, the high flow nasal cannula market size is estimated to worth US$ 15,926.4 million by 2030 and expanding growth at a CAGR of 11.3% from 2021 to 2030.

The global healthcare cloud infrastructure market size is estimated to hit US$ 157.8 billion by 2030 and is growing at a CAGR of 14.8% from 2021 to 2030.

PacBio, a leading provider of high-quality, highly accurate sequencing solutions, announced PacBio’s essential contribution to the completion of the first truly complete human reference genome.

The global antibacterial drugs market for the historical period 2017–2018 and forecast period 2019–2027, high prevalence of infectious diseases, increase in research and developmental activities, and increase in initiatives by government in healthcare sector are the factors projected to drive the global antibacterial drugs market during the forecast period.

The global asthma treatment marketwill rise from a value of US$ 25.6 Bn in 2019 to US$ 30.5 Bn by 2027, and it is anticipated that an increase in the number of FDA-approved products in parallel to the increasing awareness among asthma patients regarding quality care will drive the steady odyssey of the market.

According to the report, the global osteoporosis drugs market was valued at US$ 11.5 Bn in 2018 and is anticipated to contract at a CAGR of 0.3% from 2019 to 2030

The global pharmaceutical excipients market was valued at US$ 6.9 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027.

According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22.41 Bn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2030.

According to the report, the global scar treatment market was valued at US$ 15.08 Bn in 2018 and is projected to expand at a CAGR of 8.3% from 2019 to 2030.